Rare cancers are less known and pose challenges due to limited research and diagnostic difficulties. Environmental factors, ...

Cancer survivor Zoe Plastiras hopes her message provides some reassurance by highlighting advances in cancer treatment.

Dan Evans, 19, from Newark in Nottinghamshire, described his huge relief ringing the "cancer-free bell" at the teenage cancer ...

A 41-year-old man was evaluated for swelling in the ankles and syncope. CT of the chest showed bilateral mediastinal and ...

Association between adjuvant component of perioperative chemotherapy and survival outcomes in resected gastric cancer (GC).

Adding pamrevlumab to standard chemotherapy did not improve survival in patients with locally advanced pancreatic cancer ...

The CHMP recommends approval of Bristol Myers' Opdivo plus Yervoy for the first-line treatment of hepatocellular carcinoma ...

Keytruda (pembrolizumab) plus Lenvima (lenvatinib) and chemotherapy improved progression-free survival but did not achieve statistical significance for overall survival in patients with advanced ...

A 19-year-old is celebrating being cancer-free – a year after he was told that there was no hope and to “go home and make memories with his family”.

CT of the chest showed bilateral mediastinal and hilar lymphadenopathy, as well as an 8-mm nodule in the right lower lobe. What is the diagnosis ... smoking-related lung cancer in his maternal ...

High disease control rate and strong interim safety results observed in pancreatic cancer patients across three trials exploring the use of ...

Bristol Myers Squibb today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of Breyanzi® (lisocabtagene maraleucel; ...